Condition
Mal de Debarquement Syndrome
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Withdrawn2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04612010Early Phase 1WithdrawnPrimary
WAVES for Mal de Debarquement Syndrome
NCT02540616Not ApplicableWithdrawnPrimary
Transcranial Electrical Stimulation for Mal de Debarquement Syndrome
NCT02470377Not ApplicableCompletedPrimary
Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome
Showing all 3 trials